Practitioner's trial on the efficacy of antihypertensive treatment in the elderly hypertension (The PATE-hypertension study) in Japan

American Journal of Hypertension

Volumn 13, Issue 5 II SUPPL., 2000, Pages 461-467

  Ogihara, Toshio ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cardiovascular events; Delapril; Manidipine; PATE Hypertension study; Tolerability

Indexed keywords

CALCIUM ANTAGONIST; CAPTOPRIL; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MANIDIPINE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; AORTA ANEURYSM; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; BRAIN INFARCTION; CANCER INCIDENCE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COUGHING; DEATH; DRUG EFFICACY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICIAN; PRIORITY JOURNAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; DELAYED-ACTION PREPARATIONS; DIHYDROPYRIDINES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; INDANS; JAPAN; MALE; PROSPECTIVE STUDIES; SAFETY; SURVIVAL RATE;

EID: 0034026303     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00215-0     Document Type: Article

References (25)

1. Pahor M, Guralink JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ: Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-1197.
2. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R: Treatment of mild hypertension study: final results. JAMA 1993;270:713-724.
3. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A: Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350: 757-764.
4. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-1762.
5. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BK, Bjorck JE: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999;353:611-616.
6. The GLANT Study Group: A 12-month comparison of ACE inhibitor and Ca antagonist therapy in mild to moderate essential hypertension: The GLANT Study. Hypertens Res 1995;18:235-244.
7. Omae T, Matsuoka H, Arakawa K, Imura O, Ishii M, Ogihara T, Kaneko Y, Kuramochi M, Kokubu T, Takeda R, Hiwada K, Fukiyama K, Fujishima M, Yamada K, Yoshinaga K, Shimizu U, Nobutomo K: GLANT Study. Nippon Iji-Shinpo 1993;3630:26-34(in Japanese).
8. Saruta T, Nishikawa K: Characteristics of a new angiotensin converting enzyme inhibitor: delapril. Am J Hypertens 1991;4(suppl):23S-28S.
9. Nagaoka A: Pharmacologic characteristics of a new calcium antagonist, manidipine: beneficial effects on renal circulation and vascular changes. Am Heart J 1993;125:560-565.
10. Fogari R, Zoppi A, Lusardi P, Mugellini A: Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Blood Pressure 1996;5(suppl 5):24-28.
11. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas J, Deedwania PC, Ney DE, Snavely DB, Chang PI: Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349: 747-752.
12. Alderman MH, Cohen H, Roque R, Madhaven S: Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997;349:594-598.
13. Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial (EWPHE). Lancet 1985;i:1349-1354.
14. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension final results from the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:3255-3264.
15. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-hypertension). Lancet 1991;338:1281-1285.
16. MRC Working Party: Medical Research Council Trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
17. Liu L, Wang JG, Gong L, Liu G, Staessen JA: Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998;16:1823-1829.
18. Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Page V, Ghadirian P, LeLorier J, Hamet P: Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14:1237-1245.
19. Kaplan NM: Critical comments on recent literature. Age and the response to antihypertensive drugs. Am. J. Hypertens 1989;2:213-215.
20. Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A, Forette F, Leonetti G, Nissinen A, O'Malley K: Relation between mortality and treated blood pressure in elderly patients with hypertension report of the European Working Party on High Blood Pressure in the Elderly. Br Med J 1989;298:1552-1556.
21. Lever AF, Ramsay LE: Treatment of hypertension in the elderly. J Hypertens 1995;13:571-579.
22. Lever AF, Hole DJ, Gillis CR, McCallum IR, Mclnnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW: Do inhibitors of angiotensin I-converting enzyme protect against risk of cancer? Lancet 1998; 179-184.
23. Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, Wallace RB, Havlik RJ: Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-497.
24. Ogihara T, Morimoto S, Nakahashi T, Shimamoto K, Matsumoto M, Ouchi Y, Matsuoka H, Hiwada K, Fujishima M: Strategy for treatment of hypertension in the elderly in Japan. Jpn J Geriat Soc 1994;31:396-403 (in Japanese).
25. Muratani H, Fukiyama K, Kamiyama T, Kimura Y, Abe K, Isii M, Fujii J, Kuwajima Z, Shiomi T, Kawano Y, Mikami H, Ibayashi S, Omae T: Current status of antihypertensive therapy for elderly patients in Japan. Hypertens Res 1996;19:281-290.